Table 3.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age/gender | 11 years/M | 13 years/F | 13 years/M | 4 years/M | 17 years/M | 17 years/F | |||||||
Medical history |
|
|
|
|
|
Breast reduction | |||||||
Acute COVID | March 2020 | March 2020 | August 2020 | March 2020 | March 2020 | September 2020 | |||||||
Long‐COVID consult date | December | December | October | August | September | November | |||||||
Symptoms of acute COVID‐19 |
|
|
|
|
|
|
|||||||
Hospitalization | No | No | No | No | No | No | |||||||
Initial treatment | Salbutamol (with effect), fluticasone propionate | Salbutamol (no effect) | None | Broad‐spectrum antibiotics | Fluticasone/salmeterol & Physiotherapy | None | |||||||
Infection source | Parents (medical history) | Parents (medical history) | Parents (RT‐PCR positive) | Parents (RT‐PCR positive) | Unknown | Unknown | |||||||
Symptoms of long‐covid |
|
|
|
|
|
|
|||||||
Missing school | Yes | Yes | Yes | n/a | Yes | Yes |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID test | PCR | Not done | Not done | Not done | Not done | Negative | Positive | ||||||
Serology results | Negative | Negative | Positive | Negative | Positive | Not done | |||||||
Blood tests | Full blood count | Not done | Normal | Normal | Normal | Normal | Normal | ||||||
Inflammation markers | Not done |
|
Normal | Normal | Normal | Normal | |||||||
kidney function | Not done | Normal | Normal | Normal | Normal | Normal | |||||||
liver function | Not done | Normal ALP 345 U/L (high) | Normal | Not done | Not done | Normal | |||||||
thyroid function | Not done | Not done | Normal | Normal | Not done | Not done | |||||||
Other | Not done |
|
|
|
|
|
|||||||
Cardiac evaluation | ECG/Holter | Right axis deviation (135°) | Normal | Normal (stress ECG: normal) |
|
Normal |
Negative T wave in V3 and III (ECG before COVID‐19 showed a negative T wave in II, but not in V3) |
||||||
Echocardiogram | Normal | Not done | Normal | Normal | Not done | Not done | |||||||
Pulmonary evaluation | CT‐thorax | Not done | Not done | Normal | Not done | Normal | Normal | ||||||
Chest X‐ray | Not done | Not done | Not done | Normal | Not done | Not done | |||||||
Flow‐Volume |
FVC 84% and 97%, FEV1 81% and 99% before and after administration of salbutamol |
FVC 102% and FEV1 102.4% after salbutamol | FVC 81% and FEV1 81% after salbutamol | Not done | FVC 90% and FEV1 93% after salbutamol | FVC 80% and FEV1 87% after salbutamol | |||||||
Pattern | Obstructive curve | Normal | Normal | Normal | Normal | ||||||||
Reversibility | Fully reversible | No | No | No | No | ||||||||
Body plethysmography | Not done | Not done | TLC 76%, RV 74% | Not done | Normal | TLC 88%; RV 86% | |||||||
CO diffusion capacity | Not done | Not done | Normal | Not done | Normal | Normal (111%) | |||||||
Exercise testing | Not done | Treadmill test:
|
CPET: VO2 max: 24 ml/min kg (51%), HF max: 163/min. RER 1.18: conclusion: dysfunctional breathing and reduced physical fitness, no circulatory nor ventilator abnormalities. |
Not done |
Treadmill test: Anxiety during testing with hyperventilation due to exhaustion. No signs of exercised induced bronchoconstriction, SaO2 reduced to 90% while exercising. |
Not done |
Abbreviations: ALP, alkaline phosphatase; CMV, cytomegalovirus; CPET, cardiopulmonary exercise testing; EBV, Ebstein Barr Virus; ECG, electrocardiogram; ESR, erythrocyte sedimentation rate; FEV1, forced expiratory volume in 1 s; FT4, free thyroxin fraction; FVC, forced vital capacity; HF, heart frequency; INR, International Normalized Ratio; N/a, not applicable; O2, oxygen; RER, respiratory exchange rate; RV, residual volume; SSYC, Shigella, Salmonella, Yersinia, Campylobacter; TFT, triple feces test; TLC, total lung capacity; TSH, thyroid stimulation hormone; VO2 max, maximum oxygen absorption.